🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9 results for “Moleculin Biotech” Clear

  1. CYTARABINE, CYTARABINE, Liposomal Annamycin, 0.9% Sodium Chloride Injection, USP/Ph. Eur./BP/JP

    Moleculin Biotech

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  2. Placebo in combination with Cytarabine Injection

    Moleculin Biotech

    Acute Myeloid Leukaemia (AML)

    phase 3 small molecule active

    1 trial

  3. ALEXAN, 50 MG/ML, ROZTWÓR DO INFUZJI, Liposomal Annamycin

    Moleculin Biotech

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  4. Liposomal Annamycin

    Moleculin Biotech

    Leukemia, Myeloid, Acute

    phase 2 small molecule completed

    3 trials

  5. Liposomal Annamycin (L-Annamycin)

    Moleculin Biotech

    Sarcoma,Soft Tissue

    phase 2 small molecule completed

    1 trial

  6. MOL4239

    Moleculin Biotech

    Psoriasis

    phase 2 small molecule completed

    1 trial

  7. STAT3 Inhibitor WP1066

    Moleculin Biotech

    Glioblastoma, IDH-Wildtype

    phase 2 small molecule active

    1 trial

  8. WP1122

    Moleculin Biotech

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  9. WP1220

    Moleculin Biotech

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources